Transcriptomic analysis of human gastric cancer cell lines following T-DXd treatment

ABSTRACT: Despite the clinical success of trastuzumab deruxtecan (T-DXd) in treating HER2-positive gastric cancers (GCs), its precise immunomodulatory mechanisms remain elusive. This study investigates T-DXd's immune-related actions in GC cells through RNA sequencing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE245851 | GEO | 2024/10/20

REPOSITORIES: GEO